All Dr Chris Barbosa (Vice President of Technology Development - Acuitas Therapeutics) articles
-
ArticleAdvancing gene editing: the role of lipid nanoparticles in CRISPR delivery
CRISPR therapies depend on delivery and lipid nanoparticles are emerging as a more flexible and scalable option than viral vectors.